Jaws Acquisition in an 8-K filing said shareholders overwhelmingly approved the SPAC’s merger with Cano Health,
The transaction values Cano at an enterprise value of $4.4 billion and is expected to provide up to $1.49 billion in cash proceeds, including a fully committed PIPE of $800 million.
The PIPE includes $50 million from Barry Sternlicht, Chairman of Jaws, as well as commitments from funds affiliated with Fidelity Management & Research Company, funds and accounts managed by BlackRock, Third Point and Maverick Capital.
The deal is expected to close today, with Cano shares and warrants to begin trading tomorrow on the NYSE under CANO and CANO.WS, respectively. Read more.
